Home2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Previous close
$13.58
Day range
$13.46 - $13.92
Year range
$11.32 - $21.10
Market cap
61.13B HKD
Avg Volume
4.36M
P/E ratio
14.25
Dividend yield
2.18%
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 10.16B | -6.56% |
Operating expense | 4.10B | -8.74% |
Net income | 609.73M | -38.22% |
Net profit margin | 6.00 | -33.92% |
Earnings per share | — | — |
EBITDA | 1.64B | 1.81% |
Effective tax rate | 22.80% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 15.02B | -6.45% |
Total assets | 113.75B | 5.93% |
Total liabilities | 56.21B | 7.41% |
Total equity | 57.54B | — |
Shares outstanding | 2.67B | — |
Price to book | 0.78 | — |
Return on assets | 2.16% | — |
Return on capital | 2.66% | — |
Cash Flow
Net change in cash
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 609.73M | -38.22% |
Cash from operations | 917.31M | 5.05% |
Cash from investing | -1.19B | -768.33% |
Cash from financing | 98.64M | -65.02% |
Net change in cash | -151.74M | -115.96% |
Free cash flow | -1.85B | 45.37% |
About
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
CEO
Founded
1994
Website
Employees
40,370